Clinical Trial Update: Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls [Phase 1]

View source ↗

Summary

Phase 1 study of BPN14770 in participants with severe renal impairment and healthy controls has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• BPN14770

Snippet

Sponsor: Shionogi | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED